Needham analyst Michael Matson maintained a Hold rating on Resmed today. The company’s shares closed yesterday at $271.94. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

It is the third time charges have been brought under foreign interference laws introduced in Australia in 2018, and the first time a Chinese national has been charged under the legislation.